1313 related articles for article (PubMed ID: 26224857)
1. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
[TBL] [Abstract][Full Text] [Related]
2. The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease.
Aimé P; Karuppagounder SS; Rao A; Chen Y; Burke RE; Ratan RR; Greene LA
Neurobiol Dis; 2020 Mar; 136():104725. PubMed ID: 31911115
[TBL] [Abstract][Full Text] [Related]
3. ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin.
Sun X; Liu J; Crary JF; Malagelada C; Sulzer D; Greene LA; Levy OA
J Neurosci; 2013 Feb; 33(6):2398-407. PubMed ID: 23392669
[TBL] [Abstract][Full Text] [Related]
4. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
[TBL] [Abstract][Full Text] [Related]
5. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.
Malagelada C; Ryu EJ; Biswas SC; Jackson-Lewis V; Greene LA
J Neurosci; 2006 Sep; 26(39):9996-10005. PubMed ID: 17005863
[TBL] [Abstract][Full Text] [Related]
6. Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease.
Sun X; Aimé P; Dai D; Ramalingam N; Crary JF; Burke RE; Greene LA; Levy OA
Exp Neurol; 2018 May; 303():95-107. PubMed ID: 29432724
[TBL] [Abstract][Full Text] [Related]
7. RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells.
Pranski EL; Dalal NV; Sanford CV; Herskowitz JH; Gearing M; Lazo C; Miller GW; Lah JJ; Levey AI; Betarbet RS
Neurobiol Dis; 2013 Jun; 54():264-79. PubMed ID: 23318928
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
9. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P
Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984
[TBL] [Abstract][Full Text] [Related]
10. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
[TBL] [Abstract][Full Text] [Related]
11. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
Pirooznia SK; Yuan C; Khan MR; Karuppagounder SS; Wang L; Xiong Y; Kang SU; Lee Y; Dawson VL; Dawson TM
Mol Neurodegener; 2020 Mar; 15(1):17. PubMed ID: 32138754
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
Park JS; Choe K; Lee HJ; Park TJ; Kim MO
J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
[TBL] [Abstract][Full Text] [Related]
13. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA
Scott L; Karuppagounder SS; Neifert S; Kang BG; Wang H; Dawson VL; Dawson TM
J Neurosci; 2022 Dec; 42(49):9263-9277. PubMed ID: 36280265
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Zn
Tamano H; Nishio R; Morioka H; Takeda A
Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
[TBL] [Abstract][Full Text] [Related]
16. Activating transcription factor-4 promotes neuronal death induced by Parkinson's disease neurotoxins and α-synuclein aggregates.
Demmings MD; Tennyson EC; Petroff GN; Tarnowski-Garner HE; Cregan SP
Cell Death Differ; 2021 May; 28(5):1627-1643. PubMed ID: 33277577
[TBL] [Abstract][Full Text] [Related]
17. Forkhead Box O3a requires BAF57, a subunit of chromatin remodeler SWI/SNF complex for induction of p53 up-regulated modulator of apoptosis (Puma) in a model of Parkinson's disease.
Sanphui P; Kumar Das A; Biswas SC
J Neurochem; 2020 Sep; 154(5):547-561. PubMed ID: 31971251
[TBL] [Abstract][Full Text] [Related]
18. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
Panicker N; Kam TI; Wang H; Neifert S; Chou SC; Kumar M; Brahmachari S; Jhaldiyal A; Hinkle JT; Akkentli F; Mao X; Xu E; Karuppagounder SS; Hsu ET; Kang SU; Pletnikova O; Troncoso J; Dawson VL; Dawson TM
Neuron; 2022 Aug; 110(15):2422-2437.e9. PubMed ID: 35654037
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin 3 secreted by human adipose-derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis.
Lian C; Huang Q; Zhong X; He Z; Liu B; Zeng H; Xu N; Yang Z; Liao C; Fu Z; Guo H
FASEB J; 2021 Jul; 35(7):e21748. PubMed ID: 34152016
[TBL] [Abstract][Full Text] [Related]
20. Linalool, a Fragrance Compound in Plants, Protects Dopaminergic Neurons and Improves Motor Function and Skeletal Muscle Strength in Experimental Models of Parkinson's Disease.
Chang WH; Hsu HT; Lin CC; An LM; Lee CH; Ko HH; Lin CL; Lo YC
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
